Condition
Hydrocephalus in Infants
Total Trials
5
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (1)
P 4 (1)
Trial Status
Recruiting1
Enrolling By Invitation1
Not Yet Recruiting1
Completed1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07547826Phase 4Not Yet Recruiting
Efficacy and Cost-Effectiveness of Topical Vancomycin Powder in Preventing Pediatric Ventriculoperitoneal Shunt Infections Across Different Etiologies
NCT06693752Phase 2RecruitingPrimary
CEUS Evaluation of Hydrocephalus in Neonates and Infants
NCT06310213Not ApplicableEnrolling By InvitationPrimary
Non-Invasive Pressure Monitor for Neonates & Infants at Risk of Developing Hydrocephalus
NCT05762848CompletedPrimary
Clinical Application and Functionality for an Application for Measurement of Head Circumference.
NCT04229693UnknownPrimary
Cerebrospinal Fluid Proteom in Dependence of Intranasal Breast Milk
Showing all 5 trials